The New York Stock Exchange started up on Thursday, after records narrowly broken the day before by the Dow Jones and the S&P 500, in a very limited market two days before the end of the year.
At 3.10 p.m. GMT, the Dow Jones advanced 0.18%, the Nasdaq 0.39%. The S&P 500, which notched its 70th record of the year, rose 0.17%.
At this rate, despite the few exchanges, Wall Street was heading towards new records.
On Wednesday, the Dow Jones index and the S&P 500 had reached new highs at 36,488.63 points (+ 0.25%) and 4,793.06 points (+ 0.14%). The predominantly technological Nasdaq dropped 0.10% to 15,766.22 points.
“The news is lacking but the bias of the season is there,” said Patrick O’Hare of Briefing.com referring to the stock market tradition of the “Santa Clause rally”. She wants the market to have been up 80% of the time since 1928 in the last week of the year.
So far over the week, the Dow Jones, which has risen six in a row, has advanced 1.5%, the S&P 500 1.4% and the Nasdaq 0.7%.
Over the year, the stock index rose 19.2%, the S&P 500 jumped 28.4% and the Nasdaq 22.5%.
“We can expect another session with weak trading today”, which amplifies the movement of the indices, added the analyst.
Investors are still monitoring Omicron’s development but with less anxiety “focusing on signs that this variant is less virulent even though it is more transmissible,” Schwab analysts said.
Among the few indicators of the week, weekly jobless claims in the United States fell back below the 200,000 mark during Christmas week.
The four-week enrollment average is the lowest in over 50 years at 199,250. These figures were likely to support the market, noted analysts.
Bond yields were stable at 1.53% versus 1.54% the previous day for 10-year Treasuries.
The titles of the American laboratory Biogen (-7.29%, 239 dollars), specializing in particular in neurological diseases like Alzheimer’s, lost part of the ground gained the day before after the Korean group Samsung denied, in an official document in Korea according to the press, be in negotiations for the acquisition of Biogen.
The day before Biogen had climbed 9.5% on press information valuing the group at $ 42 billion.
The JetBlue share (+ 0.49% to 14 dollars) held up well to the announcement of the New York-based airline that it was canceling 1,280 flights until January 13 because of infected personnel.
Memory card maker Micron Technology lost 2.42% to $ 93.94 after reporting a production delay at its Xi’an plant in China due to containment measures.
Tesla lost 0.91% to $ 1,076 after recalling 475,000 vehicles for camera problems.